account_balance
Investment manager · 13F filer · SEC CIK 1583977
Cormorant Asset Management, LP
Reported value$1.95Bas of Jun 30, 2026
Positions50 13 new, 9 sold out
Top 10 weight59.2%PRAX alone is 11%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
PRAXPraxis Precision Medicines I
11.0%Trimmed −28%
BBOTBridgebio Oncology Therapeut
7.0%
PBLSParabilis Medicines Inc
6.5%New
RAPPRapport Therapeutics Inc
5.7%Trimmed −10%
ERASErasca Inc
5.6%Added +3%
EWTXEdgewise Therapeutics Inc
5.2%Trimmed −23%
EYPTEyepoint Inc
5.1%Trimmed −15%
ALMSAlumis Inc
4.7%Trimmed −17%
ABVXAbivax SA
4.6%Trimmed −11%
DNTHDianthus Therapeutics Inc
3.7%Trimmed −21%
DRUGBright Minds Biosciences Inc
3.2%Trimmed −15%
MLTXMoonlake Immunotherapeutics
3.2%Trimmed −28%
PRAXPraxis Precision Medicines I
11.0%Trimmed −28%
BBOTBridgebio Oncology Therapeut
7.0%
PBLSParabilis Medicines Inc
6.5%New
RAPPRapport Therapeutics Inc
5.7%Trimmed −10%
ERASErasca Inc
5.6%Added +3%
EWTX5.2%EYPT5.1%ALMS4.7%ABVX4.6%DNTH3.7%DRUG3.2%MLTX3.2%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
PRAX Praxis Precision Medicines I 11.0% Trimmed −28%BBOT Bridgebio Oncology Therapeut 7.0% HeldPBLS Parabilis Medicines Inc 6.5% NewRAPP Rapport Therapeutics Inc 5.7% Trimmed −10%ERAS Erasca Inc 5.6% Added +3%EWTX Edgewise Therapeutics Inc 5.2% Trimmed −23%EYPT Eyepoint Inc 5.1% Trimmed −15%ALMS Alumis Inc 4.7% Trimmed −17%ABVX Abivax SA 4.6% Trimmed −11%DNTH Dianthus Therapeutics Inc 3.7% Trimmed −21%DRUG Bright Minds Biosciences Inc 3.2% Trimmed −15%MLTX Moonlake Immunotherapeutics 3.2% Trimmed −28%
What changed